0 Ratings

ID

34224

Description

The ABC Trial Does All-Blood Cardioplegia Prevent Blood Transfusion in Cardiac Surgery? A Single Centre Pilot Study; ODM derived from: https://clinicaltrials.gov/show/NCT01623193

Link

https://clinicaltrials.gov/show/NCT01623193

Keywords

  1. 1/15/19 1/15/19 -
Copyright Holder

see on clinicaltrials.gov

Uploaded on

January 15, 2019

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :


    No comments

    In order to download data models you must be logged in. Please log in or register for free.

    Eligibility Coronary Artery Disease NCT01623193

    Eligibility Coronary Artery Disease NCT01623193

    Inclusion Criteria
    Description

    Inclusion Criteria

    Alias
    UMLS CUI
    C1512693 (Inclusion)
    patients (male and female) undergoing isolated coronary artery bypass grafting,
    Description

    ID.1

    Data type

    boolean

    isolated aortic or mitral repair or replacement, and
    Description

    ID.2

    Data type

    boolean

    combined aortic or mitral valve repair or replacement and
    Description

    ID.3

    Data type

    boolean

    coronary bypass grafting
    Description

    ID.4

    Data type

    boolean

    Exclusion Criteria
    Description

    Exclusion Criteria

    Alias
    UMLS CUI
    C0680251 (Exclusion Criteria)
    reoperation,
    Description

    ID.5

    Data type

    boolean

    endocarditis,
    Description

    ID.6

    Data type

    boolean

    dialysis dependant renal failure,
    Description

    ID.7

    Data type

    boolean

    pre-operative ecmo or lvad support,
    Description

    ID.8

    Data type

    boolean

    contraindication to blood transfusion (ie. jehovah's witness), and
    Description

    ID.9

    Data type

    boolean

    use of irreversible anti-platelet (other than asa) and anticoagulant agents within 48h (ie. plavix, dabigitran, gpiib/iiia inhibitors, argatroban).
    Description

    ID.10

    Data type

    boolean

    Similar models

    Eligibility Coronary Artery Disease NCT01623193

    Name
    Type
    Description | Question | Decode (Coded Value)
    Data type
    Alias
    Item Group
    C1512693 (UMLS CUI)
    ID.1
    Item
    patients (male and female) undergoing isolated coronary artery bypass grafting,
    boolean
    ID.2
    Item
    isolated aortic or mitral repair or replacement, and
    boolean
    ID.3
    Item
    combined aortic or mitral valve repair or replacement and
    boolean
    ID.4
    Item
    coronary bypass grafting
    boolean
    Item Group
    C0680251 (UMLS CUI)
    ID.5
    Item
    reoperation,
    boolean
    ID.6
    Item
    endocarditis,
    boolean
    ID.7
    Item
    dialysis dependant renal failure,
    boolean
    ID.8
    Item
    pre-operative ecmo or lvad support,
    boolean
    ID.9
    Item
    contraindication to blood transfusion (ie. jehovah's witness), and
    boolean
    ID.10
    Item
    use of irreversible anti-platelet (other than asa) and anticoagulant agents within 48h (ie. plavix, dabigitran, gpiib/iiia inhibitors, argatroban).
    boolean

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial